We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$43.9B
1-Year Est. Return
121.74%
This Fund
S&P 500
This Quarter
Est. Return
+76.37%
1 Year Est. Return
+121.74%
3 Year Est. Return
+237.51%
5 Year Est. Return
+285.6%
10 Year Est. Return
+728.42%
AUM
$43.9B
AUM Growth
+$19.3B
(+78%)
Cap. Flow
+$7.8B
Cap. Flow
% of AUM
17.77%
Top 10 Holdings %
Top 10 Hldgs %
40.95%
Holding
1,167
New
110
Increased
651
Reduced
370
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.05B |
| 2 |
Broadcom
AVGO
|
+$642M |
| 3 |
Micron Technology
MU
|
+$589M |
| 4 |
TSMC
TSM
|
+$428M |
| 5 |
Apple
AAPL
|
+$366M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$497M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$69.2M |
| 3 |
Tesla
TSLA
|
+$56.2M |
| 4 |
Marvell Technology
MRVL
|
+$33M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 67.72% |
| 2 | Miscellaneous | 12.15% |
| 3 | Financials | 5.66% |
| 4 | Consumer Discretionary | 3.97% |
| 5 | Industrials | 2.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Tarsus Pharmaceuticals
TARS
$3.83B
| $204K | ﹤0.01% |
+3,242
| New | +$207K |
|
1102
Wave Life Sciences
WVE
$968M
| $204K | ﹤0.01% |
35,096
+24,676
| +237% | +$164K |
|
1103
Dynatrace
DT
$14.5B
| $204K | ﹤0.01% |
+4,643
| New | +$181K |
|
1104
Harmony Biosciences
HRMY
$2.45B
| $204K | ﹤0.01% |
+5,598
| New | +$177K |
|
1105
Ally Financial
ALLY
$12.9B
| $202K | ﹤0.01% |
+4,395
| New | +$191K |
|
1106
DigitalOcean
DOCN
$14.9B
| $201K | ﹤0.01% |
+1,282
| New | +$173K |
|
1107
Organon & Co
OGN
$3.61B
| $201K | ﹤0.01% |
14,846
-8,077
| -35% | -$96.6K |
|
1108
ANI Pharmaceuticals
ANIP
$1.61B
| $201K | ﹤0.01% |
+2,427
| New | +$195K |
|
1109
Texas Roadhouse
TXRH
$12B
| $200K | ﹤0.01% |
+1,036
| New | +$176K |
|
|
ESPR
1110
DELISTED
Esperion Therapeutics
ESPR
| $200K | ﹤0.01% |
63,262
+8,717
| +16% | +$24.4K |
|
1111
ARKO Corp
ARKO
$528M
| $200K | ﹤0.01% |
24,845
+14,575
| +142% | +$102K |
|
1112
Savers
SVV
$1.57B
| $192K | ﹤0.01% |
19,055
+1,484
| +8% | +$12.9K |
|
1113
Omeros
OMER
$1.38B
| $185K | ﹤0.01% |
19,474
+7,176
| +58% | +$85.4K |
|
1114
Perrigo
PRGO
$2.02B
| $185K | ﹤0.01% |
17,784
+2,829
| +19% | +$31.1K |
|
1115
Xeris Biopharma Holdings
XERS
$1.55B
| $181K | ﹤0.01% |
22,889
-1,358
| -6% | -$8.67K |
|
1116
EVgo
EVGO
$200M
| $174K | ﹤0.01% |
90,869
+23,374
| +35% | +$47.1K |
|
|
BBOT
1117
BridgeBio Oncology
BBOT
$710M
| $172K | ﹤0.01% |
+22,606
| New | +$189K |
|
1118
Hecla Mining
HL
$13.7B
| $163K | ﹤0.01% |
+10,568
| New | +$186K |
|
1119
Arvinas
ARVN
$594M
| $162K | ﹤0.01% |
+19,535
| New | +$182K |
|
1120
Zevra Therapeutics
ZVRA
$753M
| $161K | ﹤0.01% |
+11,224
| New | +$125K |
|
|
CNH
1121
CNH Industrial
CNH
$21.9B
| $156K | ﹤0.01% |
13,872
+1,406
| +11% | +$15K |
|
1122
Phathom Pharmaceuticals
PHAT
$763M
| $138K | ﹤0.01% |
+12,756
| New | +$146K |
|
1123
Relmada Therapeutics
RLMD
$453M
| $138K | ﹤0.01% |
+19,903
| New | +$139K |
|
1124
CorMedix
CRMD
$638M
| $131K | ﹤0.01% |
16,705
+2,930
| +21% | +$23.1K |
|
1125
JELD-WEN Holding
JELD
$190M
| $122K | ﹤0.01% |
81,510
+14,887
| +22% | +$22.9K |
|
Similar funds
GAM
PCH
Rafferty Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Rafferty Asset Management held 1,167 positions worth $43.9B, up 78% from $24.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Rafferty Asset Management deployed $7.8B of net new capital in Q2 2026, opening 110 new positions and adding to 651 existing holdings. Its largest new stake was Honeywell Aerospace: 59,747 shares worth $13.2M.
By sector, the portfolio is most concentrated in Technology at 68% of assets, up from 49% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $497M trimmed.
- Rafferty Asset Management's largest Q2 2026 buy was Honeywell Aerospace: 59,747 shares worth $13.2M.
- Rafferty Asset Management added most to NVIDIA in Q2 2026, an estimated $1.05B increase.
- Rafferty Asset Management's biggest Q2 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $497M.
- Rafferty Asset Management fully exited Coterra Energy in Q2 2026, selling an estimated $13M.
- Rafferty Asset Management's ten largest holdings make up 41% of its $43.9B portfolio in Q2 2026.
- Rafferty Asset Management opened 110 new positions and closed 34 in Q2 2026.
- Rafferty Asset Management's portfolio value rose 78% quarter-over-quarter to $43.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.